# Translational Development Acquisition Corp. (TDACW)

> Financial Services · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/TDACW/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ 2.28M | $ -643.9K | N/A | $ 149.58M |
| 2025 | $ 0 | $ 6.51M | $ -622.9K | N/A | $ 175.12M |
| 2024 | $ 0 | $ -74.6K | $ -894.9K | $ 6,110.78B | $ 168.75M |
| 2023 | $ 0 | $ -525.0K | $ -221 | $ 347.5K | $ -507.7K |
| 2022 | $ 0 | $ -1.9K | $ 0 | $ 75.0K | $ 23.3K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Liabilities / Eq | 0.05 |
| Current Ratio | 0.06 |

## Other views

- [Metrics](https://sponda.capital/en/TDACW.md)
- [Charts](https://sponda.capital/en/TDACW/charts.md)
- [Compare](https://sponda.capital/en/TDACW/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.